鼻喷雾剂-话题@MedSci

#鼻喷雾剂#

9篇内容 | 800人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2193448, encodeId=7aff219344896, content=<a href='/topic/show?id=533248e474a' target=_blank style='color:#2F92EE;'>#干眼#</a> <a href='/topic/show?id=987b103432fe' target=_blank style='color:#2F92EE;'>#鼻喷雾剂#</a>, objectTitle=造福中国3亿干眼患者，比滴眼液更方便！北京同仁医院接英团队：创新鼻喷剂安全有效, objectType=article, longId=817194, objectId=3a9781e19479, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-working-in-a-hospital-PSQT2U3.jpg, objectUrl=/article/show_article.do?id=3a9781e19479, replyNumber=0, likeNumber=18, createdTime=2024-03-15, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=3a9781e19479, moduleTitle=造福中国3亿干眼患者，比滴眼液更方便！北京同仁医院接英团队：创新鼻喷剂安全有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3a9781e19479)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2123634, encodeId=e58b212363452, content=<a href='/topic/show?id=f336e29134' target=_blank style='color:#2F92EE;'>#FDA#</a>批准<a href='/topic/show?id=987b103432fe' target=_blank style='color:#2F92EE;'>#鼻喷雾剂#</a><a href='/topic/show?id=a6c1105e74ed' target=_blank style='color:#2F92EE;'>#Zavegepant#</a>上市，15分钟缓解<a href='/topic/show?id=1ffc2e613ae' target=_blank style='color:#2F92EE;'>#偏头痛#</a>，<a href='/topic/show?id=0422105e751f' target=_blank style='color:#2F92EE;'>#偏头痛网#</a><a href='/topic/show?id=d3c65861e2f' target=_blank style='color:#2F92EE;'>#新药#</a>, objectTitle=FDA批准鼻喷雾剂Zavegepant上市，15分钟缓解偏头痛, objectType=article, longId=762497, objectId=1db1e62497d5, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230312/1678654136367_4754896.jpeg, objectUrl=/article/show_article.do?id=1db1e62497d5, replyNumber=0, likeNumber=66, createdTime=2023-04-04, rootId=0, userName=侠胆医心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=1db1e62497d5, moduleTitle=FDA批准鼻喷雾剂Zavegepant上市，15分钟缓解偏头痛, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1db1e62497d5)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=2041989, encodeId=d9a6204198964, content=<a href='/topic/show?id=987b103432fe' target=_blank style='color:#2F92EE;'>#鼻喷雾剂#</a>, objectTitle=Ann Allergy Asthma Immunol：氯雷他定-伪麻黄碱和氟替卡松鼻喷雾剂治疗过敏性鼻炎的鼻腔气流比较 , objectType=article, longId=212520, objectId=7954212520a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7954212520a0, replyNumber=0, likeNumber=41, createdTime=2021-06-16, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7954212520a0, moduleTitle=Ann Allergy Asthma Immunol：氯雷他定-伪麻黄碱和氟替卡松鼻喷雾剂治疗过敏性鼻炎的鼻腔气流比较 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7954212520a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2041987, encodeId=d5f3204198e6a, content=<a href='/topic/show?id=987b103432fe' target=_blank style='color:#2F92EE;'>#鼻喷雾剂#</a>, objectTitle=重度抑郁症新药获FDA批准——强生的鼻喷雾剂Spravato, objectType=article, longId=198727, objectId=cff5198e2791, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cff5198e2791, replyNumber=0, likeNumber=56, createdTime=2021-02-26, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cff5198e2791, moduleTitle=重度抑郁症新药获FDA批准——强生的鼻喷雾剂Spravato, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cff5198e2791)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2041988, encodeId=04c2204198887, content=<a href='/topic/show?id=987b103432fe' target=_blank style='color:#2F92EE;'>#鼻喷雾剂#</a>, objectTitle=J Allergy Clin Immunol Pract：糠酸氟替卡松鼻喷雾剂在中度至重度、持续性、常年性过敏性鼻炎患者中的按需使用与常规使用的比较, objectType=article, longId=202269, objectId=975d202269ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=975d202269ea, replyNumber=0, likeNumber=54, createdTime=2021-07-28, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=975d202269ea, moduleTitle=J Allergy Clin Immunol Pract：糠酸氟替卡松鼻喷雾剂在中度至重度、持续性、常年性过敏性鼻炎患者中的按需使用与常规使用的比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=975d202269ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2041986, encodeId=8dba2041986b6, content=<a href='/topic/show?id=987b103432fe' target=_blank style='color:#2F92EE;'>#鼻喷雾剂#</a>, objectTitle=强生的抑郁症药物Spravato鼻喷雾剂，在欧洲获批, objectType=article, longId=185035, objectId=b4591850359d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b4591850359d, replyNumber=0, likeNumber=46, createdTime=2020-03-21, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b4591850359d, moduleTitle=强生的抑郁症药物Spravato鼻喷雾剂，在欧洲获批, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b4591850359d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2041985, encodeId=88cb204198521, content=<a href='/topic/show?id=987b103432fe' target=_blank style='color:#2F92EE;'>#鼻喷雾剂#</a>, objectTitle=谷氨酸受体调节剂：Spravato鼻喷雾剂获得FDA咨询委员会的批准治疗耐药性抑郁症, objectType=article, longId=160113, objectId=805016011331, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=805016011331, replyNumber=0, likeNumber=36, createdTime=2020-01-07, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=805016011331, moduleTitle=谷氨酸受体调节剂：Spravato鼻喷雾剂获得FDA咨询委员会的批准治疗耐药性抑郁症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=805016011331)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2041984, encodeId=30be20419843f, content=<a href='/topic/show?id=987b103432fe' target=_blank style='color:#2F92EE;'>#鼻喷雾剂#</a>, objectTitle=JACC：Etripamil 鼻喷雾剂治疗阵发性室上速安全有效, objectType=article, longId=145140, objectId=7b45145140d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b45145140d3, replyNumber=0, likeNumber=61, createdTime=2019-01-12, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b45145140d3, moduleTitle=JACC：Etripamil 鼻喷雾剂治疗阵发性室上速安全有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7b45145140d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2041983, encodeId=1669204198376, content=<a href='/topic/show?id=987b103432fe' target=_blank style='color:#2F92EE;'>#鼻喷雾剂#</a>, objectTitle=Turk J Med Sci：糠酸莫米松鼻喷雾剂对鼻粘膜细胞DNA影响研究, objectType=article, longId=137837, objectId=b5bb13e837ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5bb13e837ae, replyNumber=0, likeNumber=0, createdTime=2018-07-01, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5bb13e837ae, moduleTitle=Turk J Med Sci：糠酸莫米松鼻喷雾剂对鼻粘膜细胞DNA影响研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b5bb13e837ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2041982, encodeId=38582041982f8, content=<a href='/topic/show?id=987b103432fe' target=_blank style='color:#2F92EE;'>#鼻喷雾剂#</a>, objectTitle=Eur Arch Otorhinolaryngol：环孢霉素鼻喷雾剂在过敏性鼻炎中的效用评估, objectType=article, longId=119682, objectId=780711968271, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=780711968271, replyNumber=0, likeNumber=56, createdTime=2018-02-09, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=780711968271, moduleTitle=Eur Arch Otorhinolaryngol：环孢霉素鼻喷雾剂在过敏性鼻炎中的效用评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=780711968271)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

鼻喷雾剂

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#干眼# #鼻喷雾剂#

造福中国3亿干眼患者，比滴眼液更方便！北京同仁医院接英团队：创新鼻喷剂安全有效

2024-03-15发表于上海

(审核中...)

前往app查看评论内容

#FDA#批准#鼻喷雾剂##Zavegepant#上市，15分钟缓解#偏头痛#，#偏头痛网##新药#

FDA批准鼻喷雾剂Zavegepant上市，15分钟缓解偏头痛

2023-04-04发表于上海

heli0118 (审核中...)

前往app查看评论内容

#鼻喷雾剂#

Ann Allergy Asthma Immunol：氯雷他定-伪麻黄碱和氟替卡松鼻喷雾剂治疗过敏性鼻炎的鼻腔气流比较

2021-06-16

heli0118 (审核中...)

前往app查看评论内容

#鼻喷雾剂#

重度抑郁症新药获FDA批准——强生的鼻喷雾剂Spravato

2021-02-26

heli0118 (审核中...)

前往app查看评论内容

#鼻喷雾剂#

J Allergy Clin Immunol Pract：糠酸氟替卡松鼻喷雾剂在中度至重度、持续性、常年性过敏性鼻炎患者中的按需使用与常规使用的比较

2021-07-28

heli0118 (审核中...)

前往app查看评论内容

#鼻喷雾剂#

强生的抑郁症药物Spravato鼻喷雾剂，在欧洲获批

2020-03-21

heli0118 (审核中...)

前往app查看评论内容

#鼻喷雾剂#

谷氨酸受体调节剂：Spravato鼻喷雾剂获得FDA咨询委员会的批准治疗耐药性抑郁症

2020-01-07

heli0118 (审核中...)

前往app查看评论内容

#鼻喷雾剂#

JACC：Etripamil 鼻喷雾剂治疗阵发性室上速安全有效

2019-01-12

heli0118 (审核中...)

前往app查看评论内容

#鼻喷雾剂#

Turk J Med Sci：糠酸莫米松鼻喷雾剂对鼻粘膜细胞DNA影响研究

2018-07-01

heli0118 (审核中...)

前往app查看评论内容

#鼻喷雾剂#

Eur Arch Otorhinolaryngol：环孢霉素鼻喷雾剂在过敏性鼻炎中的效用评估

2018-02-09

科室
- - 订阅+
  - 更多科室
工具
服务